Participated · Equity · Apr 2025

Homemove is a proptech brand that enables users to manage the complete home move process from a single platform, offering holistic oversight, easy management, and real-time updates. Co-founded by James Freestone and Louis O'Connell Bristow and based in Norwich, England, the company serves five core verticals: estate agents, mortgages, surveys, conveyancing and removals. In three years since inception it scaled from zero to $4 million in revenue, demonstrating early market traction and customer adoption. The platform centralizes workflows from research to completion to cut administrative delays and improve customer confidence. Homemove plans to use new capital to refine its technology across those verticals, build national brand recognition, and accelerate rollout of innovative homemoving products. Homemove is an AI-driven platform that integrates estate agent valuations, mortgage comparisons, homebuyer surveys, conveyancing services, and removal bookings into a single digital moving experience. The company connects thousands of local, high-quality independent partners and books them directly with consumers through its scalable platform, handling 1000's of movers every month. Over the last 12 months Homemove has rapidly grown its revenues and market share by offering a top-rated service. Founded in 2022, the business is focusing on advancing its technological infrastructure and AI capabilities to automate evaluation and booking procedures. Future plans include expanding market reach and network, accelerating marketplace technology, delivering innovative product developments, and elevating the customer home-moving journey through personalised AI-driven experiences.

Led · Equity · Jan 2024

Deep Planet builds AI tools for viticulture that combine satellite imagery and machine learning to provide winemakers with prediction and monitoring capabilities. Its prediction SaaS platform—branded VineSignal—helps users accurately predict yields, inform optimal harvest timing, and guide decisions on soil health, disease control, irrigation and nutrient management. The platform is presented as a cost-effective, highly accurate alternative to traditional methods and aims to improve grape quality and yield resilience amid climate change. Deep Planet is also developing a 'SoilSignal' service to help project developers, farmers and businesses measure, report and verify the impact of regenerative farming. The company says the technology supports both sustainable production and profitability for vineyards. A £680,000 fundraise announced in January 2024 will fund scaling in France, the USA, Spain, Italy and South America and further product development. Deep Planet uses satellite data and machine learning to detect crop stress, methane leaks and to monitor water assets for businesses and policy makers. The company applies its technology in agriculture—working in Australia with grape farmers to identify plant stress, measure soil moisture and predict crop yields. It then recommends operational solutions, such as irrigation changes, to reduce costs, manage extreme weather and improve food and water sustainability. Deep Planet says these measures can boost food security and reduce environmental impact. The company raised £100,000 to support its sustainability projects and is pursuing additional fundraising for planned agriculture and forestry projects. Founded in 2018 by three alumnae of Oxford University’s Saïd Business School, Deep Planet is UK-based.

Participated · Seed · Nov 2022

EcoSync develops an AI-controlled property energy management system that creates digital twins of buildings to analyse temperatures and adjust heating based on occupancy. The platform enables room-by-room heating control and lets users adjust settings via a room QR code. Its technology is currently used in higher education institutions, with plans to expand into offices, hotels and commercial buildings. The company says it will use the new cash to further develop its AI technology and grow sales and marketing functions. CEO Nick Pledge stated the funding will allow EcoSync to reach a cash-positive, self-funding position. Prior to this round EcoSync had received £1.5m in seed funding, grants and other investments.

Participated · Equity · Mar 2022

Oxford Medical Products develops Sirona, an oral hydrogel tablet that expands in the stomach to reduce hunger and suppress appetite. The company has raised £2.5M in equity to conduct the first human trials of Sirona in partnership with Southampton and Bristol University Hospitals. Funding will also be used to develop line extensions targeting patients with type 2 diabetes and non-alcoholic steatohepatitis (NASH) and to begin research on a drug-delivery platform built on its core hydrogel IP. Sirona is positioned as a non-invasive, at-home alternative to gastric balloon procedures: tablets can be taken at home, remain in the stomach for several weeks, then break down and pass naturally. Oxford Medical Products was founded in 2017 by Professor Jan Czenurska and Dr Hutan Ashrafian; Dr Camilla Easter is CEO and Dr Nick Edwards joined to help commercialize the technology. Oxford Medical Products (OMP) is developing Sirona, a self-expanding hydrogel capsule that expands in the stomach to occupy space, reduce hunger, and drive significant weight loss. Sirona is designed to mimic the mechanism of a gastric balloon but can be swallowed and used at home rather than placed endoscopically. The capsules expand rapidly, provide continuous 24/7 satiety for several weeks, then gradually break down and pass naturally to preserve safety. OMP positions Sirona as a lower-cost alternative to surgical solutions, with the intention of making effective weight-loss treatment accessible to many more people. The company is currently completing pre-clinical testing, plans first human studies in 2022, and aims to launch a commercial product in 2024. OMP has begun scaling operations and hiring, including recruiting a polymer scientist to advance its platform technology.

Participated · Series A · Aug 2015

Oxford Biotrans is a University of Oxford spin-out that develops specialty chemicals using its patented enzyme technology. Its first product is natural-grade nootkatone, the flavour and scent of grapefruit, which the company says will be available in commercial quantities in the coming months. The company closed £2.5m in Series A funding to establish purpose-built facilities and expand its team. Led by CEO Jason King and Chairman Will Barton, Oxford Biotrans aims to commercialize additional flavour product targets identified for its technology. It plans to realize further scalable, green, and economically attractive enzymatic processes for these targets and will explore opportunities in other market segments.